Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Lithium-induced diabetes insipidus occurs in up to one third of patients on long-term therapy. It usually manifests during the treatment course, often with preceding signs or symptoms. We wish to highlight a case in which diabetes insipidus developed many days after cessation of long-term lithium therapy. We seek to explain this delayed onset by a discussion of the molecular and genetic changes underlying the pathogenesis of lithium-induced nephrogenic diabetes insipidus.

More information Original publication

DOI

10.1177/0310057X0703500220

Type

Journal article

Publication Date

2007-04-01T00:00:00+00:00

Volume

35

Pages

278 - 280

Total pages

2

Keywords

Age of Onset, Aged, Antimanic Agents, Diabetes Insipidus, Nephrogenic, Female, Follow-Up Studies, Humans, Lithium Carbonate